Skip to content
healthcare.dev

cetirizine hydrochloride

NDC 45802-974, cetirizine hydrochloride, solution, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-974
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090254
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-974 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE5 mg/5mL

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
45802-974-26458020974261 BOTTLE in 1 CARTON (45802-974-26) / 118 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 45802097426

    GET /v1/drugs/nadac/45802097426

Use it

Look up 45802-974 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-974 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-974. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.